Leading Healthcare & Biotech Hedge Funds surge 64% quarter-over-quarter, powered by Newcomers
|September 21st, 2014||
|The most recent Top 50 Healthcare, Pharmaceutical and Biotechnology Focused Hedge Fund list has been released, revealing that the top hedge funds now manage $129 billion in U.S. equity assets, having seen their asset jump by 64% quarter-over-quarter.|
Leading the equity asset surge are a couple of very large newcomers to the list, Viking Global Investors and Pershing Square Capital Management. While Viking Global and Pershing Square do not typically focus on any particular sector, the two hedge funds have shifted a greater percentage of their portfolios into healthcare, pharma and biotech stocks, eclipsing the 35% portfolio threshold.
Viking Global claimed the top spot on the Top 50 Healthcare, Pharmaceutical and Biotechnology Hedge Fund List, stealing it away from Larry Robbins’ Glenview Capital Management.
Glenview Capital fell to #2 on the list, with $17.2 billion in equity assets under management. Glenview Capital’s sector favorites once again include Thermo Fisher Scientific (TMO), HCA Holdings Inc (HCA) and Tenet Healthcare Corp (THC).
Over the quarter, Glenview Capital purchased 1,381,300 shares of THC, increasing its position to more than 3% of the analytical instruments and laboratory equipment company’s shares outstanding. THC is also a notable favorite of the top long-term performing Healthcare, Pharma & Biotech Hedge Funds.
Other top investors that lead the Top Healthcare, Pharma and Biotech Hedge Fund List include #3 Pershing Square Capital and #4 OrbiMed Advisors.
Ranking Methodology: The Top Healthcare, Pharmaceutical and Biotechnology Hedge Fund rankings are compiled on a quarterly basis using hedge fund firms’ overall U.S. equity assets under management. The list includes the top hedge funds that have more than 35% of their U.S. equity assets invested in U.S. listed Healthcare, Pharma & Biotech companies. To view the Top Healthcare, Pharma & Biotech Hedge Fund list in its entirety, please visit HedgeTracker’s Hedge Fund Portal.
For Detailed Investor Profiles on these Investors, click below: